The release of cytokines, adhesion molecules, and extracellular matrix parameters during and after reperfusion in human liver transplantation

Transplantation

Volumn 62, Issue 8, 1996, Pages 1118-1126

  Mueller, Andrea R ^a   Platz, Klaus Peter ^a   Haak, Marion ^a   Undi, Horst ^a   Muller, Christian ^a   Kottgen, Eckard ^a   Weidemann, Henning ^a   Neuhaus, Peter ^a  

^a HUMBOLDT UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; AZATHIOPRINE; CYCLOSPORIN A; CYTOKINE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; HYALURONIC ACID; IMMUNOSUPPRESSIVE AGENT; INOLIMOMAB; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 8; LAMININ; LYMPHOCYTE ANTIBODY; NEOPTERIN; PREDNISOLONE; SIALIC ACID; TACROLIMUS; TUMOR NECROSIS FACTOR RECEPTOR; VASCULAR CELL ADHESION MOLECULE 1;

ARTICLE; CORTICOSTEROID THERAPY; EXTRACELLULAR MATRIX; GRAFT REJECTION; GRAFT SURVIVAL; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; POSTOPERATIVE COMPLICATION; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; TREATMENT OUTCOME;

ADULT; ALANINE TRANSAMINASE; ANTIBODIES, MONOCLONAL; ASPARTATE AMINOTRANSFERASES; BIOPTERIN; CELL ADHESION MOLECULES; CYTOKINES; E-SELECTIN; EXTRACELLULAR MATRIX; GRAFT REJECTION; GRAFT SURVIVAL; HEPATIC VEINS; HUMANS; IMMUNOSUPPRESSION; INTERCELLULAR ADHESION MOLECULE-1; LIVER TRANSPLANTATION; MIDDLE AGED; NEOPTERIN; ORGAN PRESERVATION; OXYGEN; OXYGEN CONSUMPTION; RECEPTORS, INTERLEUKIN-2; REPERFUSION; REPERFUSION INJURY; RISK FACTORS; SOLUBILITY; VASCULAR CELL ADHESION MOLECULE-1;

EID: 0029910554     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199610270-00017     Document Type: Article

References (54)

1. Neuhaus P, Bechstein WO, Blumhardt G, et al. Comparison of quadruple immuno-suppression after liver transplantation with ATG or IL-2 receptor antibody. Transplantation 1993; 55: 1320.
2. Neuhaus P, Blumhardt G, Bechstein WO, et al. Comparison of FK506- and cyclosporine A-based immunosuppression in primary orthotopic liver transplantation: a single center experience. Transplantation 1995; 59: 31.
3. Starzl TE, Todo S, Fung J, Demetris AJ, Venkataremman R, Jain A. FK506 for liver, kidney, and pancreas transplantation. Lancet 1989; ii: 1000.
4. European FK506 Multicentre Liver Study Group. Randomised trial comparing tacrolimus (FK506) and cyclosporin in prevention of liver allograft rejection. Lancet 1994; 344: 423.
5. Belzer FO, Southard JH. Principles of solid-organ preservation by cold storage. Transplantation 1988; 45: 673.
6. Todo S, Nervy J, Yanaga K, Podesta L, Gordon RD, Starzl TE. Extended preservation of human livergrafts with UW solution. JAMA 1989; 261: 711.
7. Greig PD, Wolf GM, Sinclair SB, et al. Treatment of primary liver graft nonfunction with prostaglandin E1. Transplantation 1989; 48: 447.
8. Furukawa H, Todo S, Imventarza O, et al. Effect of cold ischemia time on early outcome of human hepatic allografts. Transplantation 1991; 51: 1000.
9. Haller GW, Langrehr JM, Blumhardt G, et al. Factors relevant to the developement of primary dysfunction in liver allografts. Transplant Proc 1995; 27: 1192.
10. Howard TK, Klintmalm GBG, Cofer JB, Husberg BS, Goldstein RM, Gonwa TA. The influence of preservation injury on rejection in the hepatic transplant recipient. Transplantation 1990; 49: 103.
11. Katz E, Mor E, Patel. et al. Association between preservation injury and early rejection in clinical liver transplantation: fact or myth ? Transplant Proc 1993; 25: 1907.
12. Schuppan D, Somasudaram R, Dterich W, Ehnis T, Bauer M. The extracellular matrix in proliferation and differentiation. Ann New York Acad Sci 1994; 733: 87.
13. Martin GR. Laminin and other basement membrane components. Annu Rev Cell Biol 1987; 3: 57.
14. Abrahamson DR, Caulfield JP. Distribution of laminin within rat and mouse renal, splenic, intestinal and hepatic basement membrane identified after intravenous injection of heterologous antilaminin IgG. Lab Invest 1986; 52: 169.
15. Languino RL, Gehlsen KR, Wayner E, et al. Endothelial cells use the α2β1 integrin as a laminin receptor. Cell Biol 1989; 109: 2455.
16. Grant DS, Tashiro KI, Segui-Real B, et al. Two different laminin domains mediate differentiation of human endothelial cells into cappillary-like structures in vitro. Cell 1989; 58: 933.
17. Clavien PA, Harvey PRC, Strasberg SM. Preservation and reperfusion injuries in liver allografts: an overview and synthesis of current studies. Transplantation 1992; 53: 957.
18. Kamiike W, Nakahara M, Nakao K, et al. Correlation between ATP level and bile excretion in the rat liver. Transplantation 1985; 39: 50.
19. Ploeg RD, D'Alessandro Am, Knechtle SJ, et al. Risk factors for primary dysfunction after liver transplantation - a multivariate analysis. Transplantation 1993; 55: 807.
20. Sanchez-Urazpal L, Gores GJ, Ward EM, et al. Ischemic-type biliary complications after orthotopic liver transplantation. Hepatology 1992; 16: 49.
21. Lemasters JJ, Bunzendahl H, Thurman RG. Reperfusion injury to donor livers stored for transplantation.
22. Cadwell-Kenkel JC, Currin RT, Tanaka Y, Thurman RG, Lemasters JJ. Kupffer cell activation and endothelial cell damage after storage of rat livers: effects of reperfusion. Hepatology 1991; 13: 83.
23. Spinas GA, Keller U, Brockhaus M. Release of soluble receptors for tumor necrosis factor (TNF) in relation to cireulating TNF during experimental endotoxinemia. J Clin Invest 1992; 90: 533.
24. Billiau A, Vandekerckhove F. Cytokines and their interactions with other inflammatory mediators in the pathogenesis of sepsis and septic shock. Eur J Clin Invest 1991; 21: 529.
25. Dinarello CA. Anti-interleukin-1 strategies in the treatment of septic shock syndrome. In: Baumgartner JD, Calandra T, Carlet J, eds. Mediators of sepsis: from pathophysiology to therapeutic approaches. Paris: Medicin-Sciences Flammarion, 1993: 112.
26. Dinarello CA, Gelfand JA, Wolff SM. Anticytokines strategies in the treatment of the systemic inflammatory response syndrome. JAMA 1993; 269: 1829.
27. Oppenheim JJ, Ruscetti FW, Faltynek C. Cytokines. In: Stites DP. Terr AI, eds. Basic human immunology. Norwalk, CT: Appleton & Lange, 1991; 78.
28. Abbas AK, Lichtman AH, Pober JS. Effector mechansisms of T-cell mediated immune reactions. In: Abbas AK, Lichtman AH, Pober JS, eds. Cellular and molecular immunology. Philadelphia: Saunders. 1994: 262.
29. Sehgal PB. Interleukin-6 in infection and cancer. Exp Biol Med 1990; 19S: 183.
30. Ray A, Tratter SB, Santhanam U, Helfgott DC, May LT, Sehgal PB. Regulation of expression of interleukin-6: molecular and clinical studies. Ann NY Acad Sci 1989; 557: 353.
31. + T cell clones and peripheral blood T cells. J Immunol 1992; 149: 2378.
32. Donkier V, Flament V, Gerard C, et al. Modulation of the release of cytokines and reduction of the shock syndrome induced by ant-CD3 monoclonal antibody in mice by interleukin 10. Transplantation 1994; 57: 1436.
33. Bogdan C, Vododvotz Y, Nathan C. Macrophage deactivation by interleukin 10. J Exp Med 1991; 174: 1549.
34. Gazzinelli RT, Oswald IP, James SL, Sher A. IL-10 inhibits parasite killing and nitrogen oxide production by IFN-γ-activated macrophages. J Immunol 1992; 148: 1792.
35. Cunha FQ, Moncada S, Liew FY. Interleukin 10 (IL-10) inhibits the induction of nitric oxide synthase by interferon-γ in murine macrophages. Biochem Biophys Res Commun 1992; 182: 1155.
36. De Waal Malefyt R, Abrams J, Bennett B, Figdor CG, Vries JE. Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J Exp Med 1991; 174: 1209.
37. Moore KW, O'Garra A, de Waal Malefyt R, Vieira P, Mosmann TR. Interleukin-10. Annu Rev Immunol 1993; 11: 165.
38. Fiorentino DF, Zlotnik A, Mosmann TR, Howard M, O'Garra A. IL-10 inhibits cytokine production by activated macrophages. J Immunol 1991; 147: 3815.
39. Platt JL. Connection between cell adhesion and transplantations. Ann Surg 1994; 219: 1.
40. Bevilacqua MP, Corless C, Lo SK. Endothelial-leukocyte adhesion molecule-1. (ELAm-1): a vascular selectin that regulates inflammation. In: Cochrane GG, Gimbrone, Jr MA, eds Cellular and molecular mechanisms of inflammation: vascular adhesion molecules. San Diego, CA: Academic, 1991: 1.
41. Lobb R, Hession C, Osborn L. Vascular cell adhesion molecule-1. In: Cochrane CG, Gimbrone MA Jr, eds. Cellular and molecular mechanisms of inflammation, vascular adhesion molecules. San Diego, CA: Academic, 1991: 151.
42. Rothlein R, Barton RW, Winquist R. The role of intercellular adhesion molecule-1 (ICAm-1) in the inflammatory response. In: Cochrane CG, Gimbrone MA Jr, eds. Cellular and molecular mechanisms of inflammation: vascular adhesion molecules. San Diego, CA: Academic, 1991: 178.
43. Steinhoff G, Behrend M, Schrader B, Duijvestijn Am, Wonigeit K. Expression patterns of leukocyte adhesion molecules on human liver endothelia: lack of ELAm-1 and CD62 inducibility on sinusoidal endothelia and distinct distribution of VCAm-1, ICAm-1, ICAm-2, and LFA-3. Am J Pathol 1993; 142: 481.
44. Laurent TC. Biochemistry of hyaluronana. Acta Otolaryngol 1987; 442(suppl): 7.
45. Laurent TC, Fraser JRE. Hyaluronan. FASEB J 1992; 6: 2397.
46. Hamura Y, Ho A, Okada Y, Mori Y. Hyaluronic acid metabolism in inflamed mesenterium of guinea pig. Res Commun Chem Pathol Pharmacol 1989; 66: 311.
47. Mueller AR, Rao PN, Snyder JT, Hoffman RA, Schraut WH. Evaluation of hyaluronic acid and purine nucleoside phosphorylase in vascular and luminal effluents of small bowel grafts as parameters of preservation injury. Transplantation 1993; 55: 1225.
48. Mueller AR, Nalesnik M, Langrehr JM, Rao PN, Hoffman RA, Schraut WH. Small bowel preservation causes primarily basement membrane and endothelial rather than epithelial cell injury. Transplantation 1993; 56: 1499.
49. Reutter W, Köttgen E, Bauer C, Gerok W. Sialic acid: chemistry, metabolism and function. Cell Biol Monogr 1982; 10: 263.
50. Springer TA. Adhesion receptors of the immune system. Nature 1990; 346: 425.
51. Erbil KM, Sen SE, Zinke H, Jones JD. Significance of serum protein and lipid-bound sialic acid as a marker for genitourinary malignancies. Cancer 1986; 57: 1389.
52. Müller A, Eck M, Müller Ch, Sinha P, Köttgen E. Protein- und Lipid-gebundene N-Acethylneuraminsäure (Sialinsäure) im Serum: Tierexperimentelle Befunde und Untersuchungen zur diagnostischen Relevanz in der Humanmedizin. Anaytische Chemie 1988; 330: 450.
53. Ziegler I. Synthesis and interferon-y controlled release of pteri-dines during activation of human peripheral blood mononuclear cells. Biochem Biophys Res Commun 1985; 132: 404.
54. Henderson DC, Sheldon J, Riches P, Hobbs JR. Cytokine induction of neopterin production. Clin Exp Immunol 1991; 83: 479.